Chris Markoch
Latest: Page 3
Crocs May be a Comfortable Fit for Growth-Oriented Investors
Inflation and other macroeconomic headwinds may hold CROX stock back in the short term, but this is definitely one for your watchlist
Is Bionano Genomics a Risk Worth Taking at This Price?
Revenues are increasing, but with its meme stock heyday well in the rearview mirror, it's fair to ask whether Bionano Genomics stock is a risk worth taking
Patience, Not Panic, Should be Your Playbook After SVB Collapse
Investors are rightfully concerned about the collapse of Silicon Valley Bank, but this is a time that calls for investors to be patient and not panic
Can Investors Trust Consumers to Lift American Outdoor Brands?
AOUT stock could offer some value for growth-hungry investors. But achieving that growth will depend on the continued strength of the consumer
Solo Brands May Remind Investors Why Cash is King
An increase in a key fundamental metric gives investors some food for thought when considering taking a position in Solo Brands.
Zymeworks为美元提供了希望ore than Just Long-Term Investors
Zymeworks stock is up nearly 5% since reporting earnings and a rally that has put ZYME stock over 25% in the last 12 months and could send the stock higher
